The notified amendment was a risk management proposal for the management of phytoplasmas on ornamental plants for planting imported into New Zealand. This addendum does not extend the scope of the previously notified regulation, nor will it potentially affect Members as this is a trade enabling amendment.
In response to comments on our first proposal, we have adjusted a couple of risk management measures as follows:
• Amended high certainty pathways to restrict them to the commodity type that has been imported into New Zealand (e.g., tissue culture), rather than all commodity types. The high certainty pathways now are:
1. Alstroemeria tissue culture from the Netherlands;
2. Anemone bulbs from Israel and the Netherlands;
3. Dahlia bulbs from the Netherlands;
4. Gerbera tissue culture from India;
5. Narcissus bulbs from the United Kingdom;
6. Paeonia bulbs from the Netherlands;
7. Rosa whole plants, cuttings and tissue culture from Australia, Denmark, France, Germany, Ireland, Netherlands, and the United Kingdom;
8. Alstroemeria, Begonia, Dahlia, Dianthus caryophyllus, Freesia, Gladiolus, Lilium and Narcissus bulbs from the Netherlands imported under an MPI-approved propagation scheme (Naktuinbouw and Bloembollenkeuringsdienst (BKD));
9. Dianthus caryophyllus whole plants from the Netherlands imported under an MPI-approved propagation scheme (Naktuinbouw and BKD);
• Added a nine-month transitional period for the phytoplasma amendments to come into force. This is because several hosts imported as bulbs are produced in the northernhemisphere, where growing season inspection has already started.
We have now drafted the import health standard and changed the proposed date of entry into force to 14 March 2025.
|